Selective β2-AR Antagonism in Asthma
Clinical trial NCT07272135 · COMPLETED
Trial details
- NCT number
- NCT07272135
- Sponsor
- Trio Medicines Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2022-08-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.